❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Molecular Oncology ❭ News ❭

Forskning om nerveskjedesvulster omtalt på forskningsrådets hjemmeside

"Strategisk satsning på kreftforskning (KREFTSATSING)"


Link to PDF.

 
Scroll to top

Home Institute for Cancer Research Dept. of Molecular Oncology

  • Staff
  • Lothe lab
  • Skotheim lab
  • Lind lab
  • Sveen lab
  • Johannessen lab
  • Project groups
  • News
  • Technology and applications
  • Education/Early career
  • MO publication list
  • Scientific reports

Recent publications

Pharo H, Brandt-Winge S, Thorkildsen EM, Vedeld HM, Lind GE (2026)
DNA Methylation Analyses of Tissue Samples and Cell-Free DNA by Droplet Digital PCR
Methods Mol Biol, 2969, 179-193
DOI 10.1007/978-1-0716-4767-7_12, PubMed 41073866

Osterlund E, Ristimäki A, Nunes L, Kytölä S, Aho S, Heervä E, Uutela A, Lehtomäki K, Stedt H, Halonen P, Kontiainen J, Muhonen T, Kallio R, Sundström J, Ålgars A, Ristamäki R, Nieminen L, Sorbye H, Pfeiffer P, Salminen T, Nordin A, Lamminmäki A, Mäkinen MJ, Sjöblom T, Isoniemi H et al. (2025)
KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts
BJC Rep, 3 (1), 72
DOI 10.1038/s44276-025-00188-5, PubMed 41120702

Pharo H, Vedeld HM, Wahlqvist R, Lind GE (2025)
Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30
Eur Urol (in press)
DOI 10.1016/j.eururo.2025.07.028, PubMed 40998632

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)